Adis Journal Podcasts

About Adis Journal Podcasts

Listen to podcasts with key opinion leaders in multiple therapy areas, discussing hot topics including topic overviews, expert opinions and conference overviews. Brought to you by the Adis Journals Group, part of Springer Nature. The primary audience for these podcasts are healthcare professionals, and are published and citable through the journals.

Publisher

Adis

Category

health & fitness · science

Language

en

Explicit

No

First episode

13 Feb 2020

Latest episode

7 Oct 2026

Latest episodes

131 episodes in the feed.

1. 

   7 Oct 2026

   Perspectives on 10 years of Immune Checkpoint Inhibitors in Merkel Cell Carcinoma: A Podcast

   In this podcast, Shailender Bhatia from the Division of Hematology and Oncology, Department of Medicine, University of Washington and Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA, Sandra D’Angelo from the Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA, and Paul Nghiem from the Department of Dermatology, University of Washington and Fred Hutchinson Cancer Center, Seattle, WA, USA summarize key studies of ICIs in advanced MCC, including clinical trials and real-world studies, and discuss clinical evidence related to practical considerations, such as elective discontinuation of ICI treatment, and treatment of patients with immunocompromised or immunosuppressed status. They also discuss initial findings from studies of ICI-based combinations in patients with advanced MCC and ICI treatment in earlier stages of MCC, and highlight the emerging role of circulating tumor DNA for predicting disease recurrence. This podcast is published open access in Targeted Oncology and is fully citeable. You can access the original published podcast article through the Targeted Oncology website and by using this link: https://link.springer.com/article/10.1007/s11523-026-01256-7. All conflicts of interest can be found online. Open Access: This podcast is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The material in this podcast is included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.

2. 

   12 Sept 2026

   Management of Adverse Events Associated with MET TKIs in Patients with Advanced NSCLC: A Podcast Discussion

   Wade T. Iams and Narjust Florez discuss safety considerations for MET TKI treatment in advanced NSCLC patients.

3. 

   31 Aug 2026

   Risk of Recurrence in Patients with HR+/HER2− Early Breast Cancer: A Podcast

   Maryam B. Lustberg, Megan-Claire Chase, Stacey Tinianov, and Kevin Kalinsky discuss HR+/HER2− early breast cancer recurrence risk, assessment, and evolving treatments in this interview.

Who has been a guest on Adis Journal Podcasts

Names identified in recent episode analyses. Showing up to five guests.

• Wade T Iams
• Narjust Florez
• Maryam B Lustberg
• Megan-Claire Chase
• Stacey Tinianov

Reach and audience

Public platform figures. Ratings count people who left a rating, not total listeners.

Spotify

5.0 / 5

2 ratings

Podcast Authority Score: 53 / 100

A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.

Quality

79

Social presence

0

YouTube

0

Engagement

68

Contact Adis Journal Podcasts

Guest appearances

Books guests

Based on episode analysis; this does not confirm that the show is currently accepting guests.

Questions about Adis Journal Podcasts